Canada ATMA to run clinical trial for synthetic psilocybin on medical professionals Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects Natalia Buendia CalvilloJanuary 11, 2022
Health and Safety Can psilocybin help smokers quit? Johns Hopkins to study impact with NIH grant It’s the first federal grant to be awarded for psychedelic treatment research in 50 years Kathryn TindaleOctober 19, 2021